Genome Web Breaking News
- Immune Response Dampened in Many Cancers by Reactivation of Embryonic Gene
- Seer Raises $17.5 M in Series C Financing Round
- Inivata to Test Liquid Biopsy Against Tissue Sequencing in French Prospective Clinical Trial
- European Patent Office Revokes Second Pacific Biosciences Patent
- Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making
Stat
- Listen: Elon Musk’s monkey cyborg, Gilead’s shifting future, & an app for anxiety
- STAT Plus: Pharmalittle: Women make ‘little progress’ in key pharma roles; FDA approves a Merck antibiotic
- STAT Plus: Archived: An online chat discussing the past — and future — of Alzheimer’s research
- STAT Plus: Novartis sets aside $700 million to settle long-running bribery allegations in the U.S.
- STAT Plus: Kronos, a startup led by Gilead alumni, raises $105 million in latest mega-round
NYT science news
Xconomy news
- Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets
- Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts
- Pandion Therapeutics Picks Corvidia’s Rahul Kakkar for CEO
- Immusoft Taps Phylogica’s Robert Hayes as Chief Scientific Officer
- Gilead Chief Scientific Officer McHutchison and Two More to Depart
Fierce Biotech
- Eisai’s prototype blood test for Alzheimer’s shows links to CSF amyloid in early disease
- Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
- EuroBiotech Report—Gilead-Galapagos, Alzheimer's fail, AM-Pharma and Abivax
- EuroBiotech: More Articles of Note
- Bischofberger-helmed Kronos bags $105M to tackle tough targets
Fierce Medical Devices
- Eisai’s prototype blood test for Alzheimer’s shows links to CSF amyloid in early disease
- Musk's Neuralink startup aims to connect brains to the web, starting next year
- Yale, Mayo Clinic tap Biofourmis’ sensors and the new Apple Watch to study digital endpoints for heart disease
- GNS Healthcare's AI patient-matching platform nets $23M from Cigna Ventures, Amgen, Celgene
- Paragon's new company to carry its AI-powered breast cancer diagnostic buy